DexCom, Inc. Class Action Lawsuit - DXCM

Company: DexCom, Inc. (NASDAQ: DXCM)
Lead Plaintiff Deadline: October 21, 2024 (Expired)
Class Definition: This lawsuit is on behalf of all investors who: (i) purchased or otherwise acquired DexCom securities between January 8, 2024 to July 25, 2024, inclusive (the “Class Period”) and/or (ii) sold DexCom put option contracts during the Class Period.

Expired

Lead Plaintiff Deadline

Oct 21, 2024

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

According to the complaint, on July 25, 2024, Dexcom announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on their execution of “several key strategic initiatives” which “did not meet [their] high standards.” Investors and analysts reacted immediately to DexCom’s revelation. The price of DexCom’s common stock declined dramatically. From a closing market price of $107.85 per share on July 25, 2024, DexCom’s stock price fell to $64.00 per share on July 26, 2024, a decline of about 40.66% in the span of just a single day.

Eligibility

In order to be eligible to join the DXCM class action lawsuit, you must have incurred a loss on shares of DexCom purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in DexCom during the relevant time frame, you have until October 21, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP